Skip to main content

Table 2 Patient compliance in various recent or ongoing clinical trials in resectable gastric cancer

From: CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

Study [reference] Treatment arm Completed (%)
SWOG [5] S→CRT 64%
MAGIC [7] CT→S→CT 42%
ACTS-GC [51] S→CT 66%
CLASSIC [40] S→CT 67%
ARTIST [59] S→CT 75%
S→CRT 82%
ST03 [31] CT→S→CT 40%
CT + B→S→CT + B 37%
TOPGEAR part 1 [27] CT→S→CT 58%
CT→CRT→S→CT 45%
FLOT4-AIO [14] CT→S→CT (3×ECF/ECX) 37%
CT→S→CT (4×FLOT) 50%
CRITICS [11] CT→S→CT 46%
CT→S→CRT 51%
  1. CT chemotherapy, CRT chemoradiotherapy, S surgery, B bevacizumab